Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

POLYPEPTIDES COMPRISING IL-6 LIGAND-BINDING RECEPTOR DOMAINS

  • Read more about POLYPEPTIDES COMPRISING IL-6 LIGAND-BINDING RECEPTOR DOMAINS
US Patent 6,664,374
Filed on 2000-11-22

Inhibition of Signal Transduction by the Binding of Non-Phosphorylated Compositions

  • Read more about Inhibition of Signal Transduction by the Binding of Non-Phosphorylated Compositions
Patent Cooperation Treaty
PCT/US97/12501
Filed on 1997-07-16

USE OF CONSTITUTIVE TRANSPORT ELEMENTS FOR HOST RANGE CONTROL

  • Read more about USE OF CONSTITUTIVE TRANSPORT ELEMENTS FOR HOST RANGE CONTROL
US Patent 6,492,166
Filed on 2001-01-19

Compositions and Methods for the Diminution or Elimination of Various Cancers

  • Read more about Compositions and Methods for the Diminution or Elimination of Various Cancers
Patent Cooperation Treaty
PCT/US00/30869
Filed on 2000-11-10

Nucleic Acids Comprising a Post-Transcriptional Regulatory Elements (PRE) and Their Uses

  • Read more about Nucleic Acids Comprising a Post-Transcriptional Regulatory Elements (PRE) and Their Uses
US Patent 6,919,442
Filed on 2001-02-26

Inhibition of ABC Transporters By Transmenbrane Domain Analogs

  • Read more about Inhibition of ABC Transporters By Transmenbrane Domain Analogs
Patent Cooperation Treaty
PCT/US2000/031817
Filed on 2000-11-17

MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS AND METHODS AND KITS FOR TARGETING..

  • Read more about MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS AND METHODS AND KITS FOR TARGETING..
US Patent 7,375,183
Filed on 2000-10-05

Recombinant Immunotoxin Directed Against the HIV-1 GP120 Envelope Glycoprotein

  • Read more about Recombinant Immunotoxin Directed Against the HIV-1 GP120 Envelope Glycoprotein
US Application 09/673,707
Filed on 2001-01-11

G-PROTEIN COUPLED RECEPTOR ANTAGONISTS

  • Read more about G-PROTEIN COUPLED RECEPTOR ANTAGONISTS
US Patent 7,105,488
Filed on 2000-10-02

Method of Eliminating Inhibitory/Instability Regions of mRNA

  • Read more about Method of Eliminating Inhibitory/Instability Regions of mRNA
US Patent 6,414,132
Filed on 2000-10-02

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1497
  • Page 1498
  • Page 1499
  • Page 1500
  • Page 1501
  • Page 1502
  • Page 1503
  • Page 1504
  • Page 1505
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health